Straits Times Index
3,294.86 +0.04 (+0.00%) Nikkei
27,522.26 -250.67 (-0.90%) Hang Seng
24,965.55 +13.20 (+0.05%) FTSE 100
7,494.13 -90.88 (-1.20%) BTC-USD
35,203.60 -1,212.11 (-3.33%) CMC Crypto 200
870.86 +628.18 (+258.85%)
Cassava Sciences, Inc. (SAVA)
After hours:
| Previous close | 37.41 |
| Open | 36.62 |
| Bid | 35.88 x 1000 |
| Ask | 36.18 x 800 |
| Day's range | 35.00 - 37.60 |
| 52-week range | 13.22 - 146.16 |
| Volume | |
| Avg. volume | 4,731,262 |
| Market cap | 1.454B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2012 |
| 1y target est | N/A |
- Business Wire
CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, December 04, 2021--Second paragraph of release dated December 3, 2021, should read: The lawsuit alleges that... (instead of The complaint, filed on January 5, 2021, alleges that...)
- Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Cassava Sciences, Inc. (SAVA) on Behalf of Shareholders
SAN DIEGO & AUSTIN, Texas, October 29, 2021--Cassava Sciences, Inc. (SAVA) Accused of Falsely Touting the Viability and Efficacy of its Lead Drug Candidate
- Business Wire
SAVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Cassava Sciences, Inc.
LOS ANGELES, October 26, 2021--Glancy Prongay & Murray LLP ("GPM"), announces that it has filed a class action lawsuit in the United States District Court for the Western District of Texas captioned Rao v. Cassava Sciences, Inc., et al., (Case No. 1:21-cv-00971) on behalf of persons and entities that purchased or otherwise acquired Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA) securities, and/or sold (wrote) Cassava put options, between September 14, 2020 and August 27, 2021
